Sotorasib: A Targeted Breakthrough in KRAS G12C- Mutated Non-Small Cell Lung Cancer. International Journal of Research in Pharmaceutical Sciences and Technology, [S. l.], v. 9, n. 3, 2026. DOI: 10.33974/7tt6d117. Disponível em: http://rubatosisjournals.com/index.php/ijrpst/article/view/519. Acesso em: 10 aug. 2026.